Discover 1,576 paid clinical trials in Jersey City, New Jersey. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,576
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants
Location: Hackensack NJ, New Hyde Park NY, Neptune City NJ,
Sponsor: Travere Therapeutics, Inc.
Sex: All
Age: 1 - 17
Code: NCT05003986
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
XTX301 in Patients With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Hackensack NJ, New Haven CT, Pittsburgh PA, Canton OH,
Sponsor: Xilio Development, Inc.
Sex: All
Age: 18+
Code: NCT05684965
Phase 1, Phase 2, Recruiting
A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease
for
Chronic Graft-versus-host-disease
Location: Hackensack NJ, New Brunswick NJ, Stony Brook NY,
Sponsor: Incyte Corporation
Sex: All
Age: 12+
Code: NCT06585774
Phase 3, Recruiting
Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
for
Sickle Cell Disease (SCD)
Location: Hackensack NJ, The Bronx NY, Philadelphia PA,
Sponsor: University of Rochester
Sex: All
Age: 3 - 20
Code: NCT06941389
Recruiting
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]
for
Advanced Melanoma
Location: Hackensack NJ, The Bronx NY, Lake Success NY,
Sponsor: Replimune, Inc.
Sex: All
Age: 12+
Code: NCT06264180
Phase 3, Recruiting
Utilization of Lung Ultrasound Score in Decision for Minimally Invasive Surfactant Administration
for
Respiratory Distress Syndrome, Newborn,
Location: Hackensack NJ
Sponsor: Hackensack Meridian Health
Sex: All
Age: 0
Code: NCT07442669
Recruiting
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
A Study in People With Advanced Cancer to Test How Well Different Doses of BI 3819026 Are Tolerated When Taken Alone and Together With Ezabenlimab
for
Advanced Solid Cancer, Metastatic Solid Cancer
Location: Hackensack NJ, New Haven CT, Nashville TN
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT07607678
Phase 1, Recruiting
Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer
for
Head and Neck Squamous Cell Carcinoma,
Location: Hackensack NJ, Richmond VA, Pittsburgh PA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06980038
Phase 2, Recruiting
Predictive Value of Lung Ultrasound for Respiratory Decompensation in Late Preterm Neonates
for
Pre-Term, Respiratory Distress of Newborn, Premature
Location: Hackensack NJ
Sponsor: Hackensack Meridian Health
Sex: All
Age: 0
Code: NCT07216053
Recruiting
ED Medicaid Support
for
Pediatric Uninsured Emergency Visits, Emergencies
Location: Hackensack NJ
Sponsor: Hackensack Meridian Health
Sex: All
Age: 18+
Code: NCT07594782
Recruiting
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
for
Anatomic Stage I Breast Cancer AJCC v8,
Location: Hackensack NJ, The Bronx NY, Greenwich CT, Stamford CT,